Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None USD 0.00(0%)
Last update at 2026-03-26T21:03:25.341804Z
Market Cap
16.66M

Momentum Score

…

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.63
Low
5.48
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
74.78M
Revenue Per Share
9.44
Gross Profit TTM
2.42M
Debt / Equity
0.57
ROE
-165.13%
Net Debt
-0.71M
ROCE
44.83%
Diluted EPS TTM
-6.24

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -54.17M -21.46M -14.33M -
Minority interest 0.21M 0.11M -0.11M -0.01M
Net income -52.63M -21.36M -14.26M -
Selling general administrative 24.86M 17.44M 11.85M -
Selling and marketing expenses 8.42M - - -
Gross profit 14.41M 2.42M 0.07M -
Reconciled depreciation 2.63M 0.77M 0.11M -
Ebit 3.29M -19.72M -12.34M -3.38M
Ebitda 5.92M -18.95M -12.22M -
Depreciation and amortization 2.63M 0.77M 0.11M -
Operating income 3.29M -18.95M -12.34M -
Other operating expenses 62.64M 21.38M 12.50M -
Interest expense 0.06M 0.08M 0.03M 0.00M
Tax provision -1.54M -0.10M - -
Interest income 0.06M - - -
Net interest income 0.06M -0.08M -0.03M -
Income tax expense -1.54M -0.10M -0.07M -
Total revenue 37.17M 8.98M 0.11M -
Total operating expenses 39.88M 21.38M 12.47M -
Cost of revenue 22.76M 6.55M 0.04M -
Total other income expense net -57.46M -2.51M -2.00M -
Net income from continuing ops -52.63M -21.36M -14.33M -
Net income applicable to common shares - -21.25M -14.17M -3.39M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 23.63M 80.99M 85.48M 19.45M 1.17M
Intangible assets 0.95M 18.10M 9.74M 0.66M 0.57M
Other current assets 1.37M 0.98M 0.04M 0.35M 0.21M
Total liab 17.22M 24.57M 8.54M 3.20M 2.48M
Total stockholder equity 6.40M 56.82M 77.17M 16.36M -1.29M
Other current liab 8.44M 7.42M 0.06M 0.60M 1.15M
Common stock - - 102.43M 27.25M 1.40M
Capital stock 0.00M 0.00M 102.43M 27.25M 1.40M
Retained earnings -142.55M -90.86M -38.54M -17.29M -2.82M
Other liab - - 1.51M 0.14M -
Good will 0.00M 23.37M 20.05M 0.43M -
Other assets - - 0.10M - -
Cash 4.38M 9.54M 37.61M 15.52M 0.14M
Total current liabilities 16.28M 17.45M 6.12M 2.74M 2.23M
Net debt -0.71M -5.39M -36.28M -14.87M 1.19M
Short term debt 2.73M 2.27M 0.43M 0.33M 1.08M
Short long term debt 1.93M 1.09M 0.02M 0.25M 1.03M
Short long term debt total 3.67M 4.14M 1.34M 0.65M 1.33M
Other stockholder equity 149.09M 150.42M 14.38M 6.36M 0.11M
Property plant equipment - - 4.98M 0.73M 0.43M
Total current assets 21.36M 31.16M 47.94M 17.63M 0.46M
Long term investments 0.00M 0.73M 2.67M - -
Net tangible assets - - 47.38M 15.27M -1.57M
Short term investments - -0.73M - - -
Net receivables 7.10M 10.55M 5.60M 1.22M 0.11M
Long term debt - - - 0.07M -
Inventory 8.51M 10.09M 3.03M 0.54M -
Accounts payable 5.11M 7.75M 5.63M 1.81M 0.33M
Accumulated other comprehensive income -0.14M -2.73M -1.11M 0.04M 0.02M
Common stock total equity - - - 27.25M 1.40M
Non currrent assets other 0.08M 0.29M 0.10M - 0.28M
Non current assets total 2.26M 49.83M 37.54M 1.82M 0.71M
Capital lease obligations 1.74M 3.06M 1.32M 0.33M 0.30M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -15.80M -2.51M -2.16M -2.51M
Change to liabilities - 3.05M -0.32M 1.23M
Total cashflows from investing activities - -14.55M -2.16M -0.52M
Net borrowings - -0.52M -1.07M 1.21M
Total cash from financing activities 4.41M 58.11M 25.82M 1.21M
Change to operating activities - -1.25M -0.03M -0.20M
Net income -52.63M -21.36M -14.33M -3.39M
Change in cash -28.08M 22.09M 15.38M 0.17M
Begin period cash flow 37.62M 15.52M 0.14M -
End period cash flow 9.54M 37.61M 15.52M 0.14M
Total cash from operating activities -15.94M -20.65M -8.42M -0.54M
Issuance of capital stock 4.55M 42.62M 30.00M -
Depreciation 2.63M 0.77M 0.11M 0.03M
Dividends paid - 2.51M 0.00M -
Change to inventory 1.22M -1.14M -0.06M -0.06M
Change to account receivables - -5.69M -0.54M -0.02M
Sale purchase of stock -0.26M 2.51M - -
Other cashflows from financing activities 0.31M 16.00M -3.10M 1.25M
Change to netincome - 4.87M 6.58M 1.81M
Capital expenditures 1.29M 3.98M 0.23M 0.17M
Change in working capital 3.82M -5.04M -0.95M -
Stock based compensation 3.40M 1.34M 4.90M -
Other non cash items 28.38M 3.74M 0.03M -
Free cash flow -17.23M -24.63M -8.65M -

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR
-0.22
0.66%
33.17 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-2.76
1.62%
167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
-0.17
0.80%
21.02 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
41.85 - 10.66 0.01 1.16 2.94 23.11

Profile*

Flora Growth Corp

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

3406 SW 26th Terrace, Fort Lauderdale, FL, United States, 33132

954 842 4989

97

Name Title Year Born
Mr. Luis Merchan Pres, CEO & Chairman 1981
Dr. Bernard Raymond Wilson F.C.A., FCA, FCPA, ICD.D, LLD(H) Advisor 1943
Mr. Elshad Garayev CPA, CPA Chief Financial Officer NA
Mr. Matthew S. Cohen Gen. Counsel 1966
Ms. Jessie Casner Chief Marketing Officer 1988
Mr. James Choe Chief Strategy Officer 1979
Mr. Aaron Atin Corp. Sec. 1984
Mr. Javier Franco VP Agriculture 1968
Ms. Holly Bell VP of Regulatory Affairs NA
Mr. Clifford A. Starke CEO & Director 1985

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…